Bio

Matthew Gardella represents publicly traded companies and companies on their way to going public, especially in capital-raising transactions and mergers and acquisitions. With nearly 30 years of experience, Matt has deep industry knowledge of the life sciences, healthcare and technology sectors. He handles IPOs, reverse mergers, private placements, and follow-on offerings for companies whose business depends on well-executed access to the capital markets. With respect to M&A, Matt regularly advises companies, boards of directors, special committees, investment banks and investors in both buy and sell-side M&A, other strategic transactions and defensive measures. In addition, Matt counsels public companies on a broad range of corporate, securities and business-related matters, including fiduciary duties, corporate governance and SEC reporting. He is consistently recognized by the publication Best Lawyers in America for corporate governance and other areas. For his M&A work, Matt is recognized by Chambers USA: America's Leading Lawyers for Business.